ArticleFrontiers in immunology2026

Discovery of co-stimulatory anti-CD28 VHHs for developing cancer immune therapeutic anti-tumor/CD3/CD28 trispecific T cell engager.

Hui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.